Yonsei E1 Plastic Surgery Clinic, Anyang, South Korea.
Department of Plastic and Reconstructive Surgery, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, 1 Singillo, Yongdeongpo-gu, Seoul, 07441, Korea.
Aesthetic Plast Surg. 2024 Sep;48(18):3627-3636. doi: 10.1007/s00266-024-03850-4. Epub 2024 Feb 7.
Transumbilical breast augmentation (TUBA) with saline implants has been considered a safe and efficient technique for decades. However, because silicone implants are more popular than saline ones, TUBA with saline implants is not widely performed. In 2014, we published a report on transumbilical breast augmentation using silicone cohesive gel implants. As we have performed transumbilical silicone breast augmentation (TUSBA) for 13 years with slight modifications, this study aimed to describe this novel technique and present accompanying patient outcomes over 5 years.
We enrolled patients desiring breast augmentation at a single center. The preoperative design was initially determined with the patients in standing positions before they underwent surgery under general anesthesia in a supine position.
Between January 2018 and December 2022, 69 women and one man underwent TUSBA at a single center. All patients underwent cohesive gel silicone implantation in the subpectoral pocket. The implant size varied from 225 to 300 mL (average 272 mL) because two patients underwent surgery with implants of different sizes due to breast asymmetry. All patients were satisfied with the surgery outcome except one who was dissatisfied because of abdominal bulging.
TUSBA offers advantages such as minimal scarring and unrestricted arm movement; thus, it can be an alternative option for patients seeking breast augmentation.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors https://www.springer.com/00266 .
经脐乳房增大术（TUBA）联合盐水植入物已被认为是一种安全有效的技术，已有数十年的历史。然而，由于硅胶植入物比盐水植入物更受欢迎，因此 TUBA 联合盐水植入物的应用并不广泛。2014 年，我们发表了一篇关于使用硅胶凝聚凝胶植入物进行经脐乳房增大术的报告。由于我们已经对硅胶进行了 13 年的经脐乳房增大术（TUSBA），并进行了轻微的修改，因此本研究旨在描述这种新技术，并介绍 5 年以上的伴随患者结果。
我们在一个单一中心招募了希望进行乳房增大术的患者。术前设计最初是在患者站立位时确定的，然后在全身麻醉下仰卧位进行手术。
2018 年 1 月至 2022 年 12 月，在一个单一中心，有 69 名女性和 1 名男性接受了 TUSBA。所有患者均在胸肌下袋内植入了凝聚型硅胶。植入物的大小从 225 到 300ml（平均 272ml）不等，因为 2 名患者由于乳房不对称，手术中植入了不同大小的植入物。除了 1 名因腹部膨出而不满意手术结果的患者外，所有患者均对手术结果满意。
TUSBA 具有疤痕最小和手臂活动不受限制等优点；因此，它可以作为寻求乳房增大术的患者的另一种选择。
证据等级 IV：本杂志要求作者为每篇文章分配一个证据等级。有关这些循证医学评级的完整描述，请参阅目录或在线作者指南 https://www.springer.com/00266 。
